TB-500 Dosage Calculator

Last updated: 2026-11-10

Sources checked: 2026-11-10

📌At a Glance: TB-500 Reconstitution Arithmetic

Non-Standardized Commercial Term: 'TB-500' is a vendor trade moniker used inconsistently to describe either full-length 43-amino acid Thymosin Beta-4 (Tβ4) or synthetic actin-binding fragments (e.g., Ac-LKKTET). Reconstitution math computes concentration for whatever mass is printed on the label, but cannot verify molecular identity.
Milligram-Scale Draw Volumes: Unlike microgram-scale peptides, TB-500 experimental test amounts are measured in milligrams (1 mg to 5 mg), producing large volumetric draws (often 40 to 80 units on a U-100 syringe).
Syringe Barrel Capacity Matters: A draw of 80 units requires a full 1.0 mL (100-unit) syringe barrel; it will not fit into a 0.5 mL (50-unit) or 0.3 mL (30-unit) syringe.
Standard Syringe Calibration: All calculations assume standard U-100 insulin syringes (100 units = 1.0 mL, or 0.01 mL per graduation mark).

⚖️Regulatory & Compound Status

Verified: 2026-11-10

TB-500 is not an FDA-approved drug, has no approved commercial pharmaceutical indications, and is not cleared for human clinical prescription therapy. The World Anti-Doping Agency (WADA) explicitly prohibits Thymosin Beta-4 and its synthetic derivatives under Section S2 of the Prohibited List at all times. In the United States, the FDA places Thymosin Beta-4 on the Category 2 bulk drug substances list under Section 503A of the FD&C Act, restricting compounding due to significant safety risks. Lyophilized vials sold online are unapproved research chemicals.

Official Sources:World Anti-Doping Code International Standard: Prohibited List (S2: Peptide Hormones),Safety Risks Associated with Certain Bulk Drug Substances Nominated for 503A/503B Compounding

ℹ️What This Tool Cannot Tell You

This calculator cannot provide medical advice, diagnosis, or clinical administration schedules.
It cannot determine whether an unapproved research vial contains full-length Thymosin Beta-4 or a synthetic peptide fragment.
It cannot verify the chemical purity, sterility, or peptide mass of research chemicals.
It cannot guarantee solution stability beyond documented USP <797> multi-dose preservative limits.

This tool converts volumetric liquid measurements and syringe tick marks only. It does not provide medical guidance, dosing schedules, or clinical administration protocols. Review our Medical & Research Disclaimer.

What Is TB-500 Reconstitution Arithmetic?

TB-500 (frequently searched as tb500) is commonly referenced in cellular and tissue repair research as a synthetic derivative or full-length counterpart to Thymosin Beta-4 (Tβ4). Endogenous Tβ4 is an abundant 43-amino-acid intracellular protein that regulates actin cytoskeleton dynamics through G-actin monomer sequestration, mediating cellular motility, tissue remodeling, and endothelial differentiation.

In laboratory evaluations, research suppliers deliver TB-500 as a freeze-dried, solid-cake lyophilized powder in glass serum vials. Reconstitution is the precise chemical dissolution of this dry cake using sterile diluent, primarily bacteriostatic water (sterile water for injection preserved with 0.9% benzyl alcohol). Because experimental protocols involve milligram-scale test quantities, using our deterministic tb-500 dosage calculator ensures accurate concentration determination and appropriate syringe barrel selection.

TB-500 Dosage Chart

This reference chart translates intended milligram test masses into volumetric draw units on a standard U-100 syringe across representative vial sizes and diluent volumes. These values represent illustrative arithmetic conversions across standardized benchmarks (1.0 mg, 2.0 mg, 2.5 mg, 5.0 mg) and do not represent clinical advice, therapeutic recommendations, or administration protocols.

Vial Size	Bac Water Added	Concentration	Example Amount	Draw Units (U-100)
2 mg	1.0 mL	2.0 mg/mL	1.0 mg	50.0 Units
2 mg	1.0 mL	2.0 mg/mL	2.0 mg	100.0 Units (1.0 mL)
5 mg	1.0 mL	5.0 mg/mL	2.0 mg	40.0 Units
5 mg	2.0 mL	2.5 mg/mL	1.0 mg	40.0 Units
5 mg	2.0 mL	2.5 mg/mL	2.0 mg	80.0 Units
10 mg	2.0 mL	5.0 mg/mL	2.0 mg	40.0 Units
10 mg	2.0 mL	5.0 mg/mL	2.5 mg	50.0 Units
10 mg	2.0 mL	5.0 mg/mL	5.0 mg	100.0 Units (1.0 mL)

TB-500 Vial Size and Diluent Conversion Matrix

The table below outlines resulting solution concentrations, unit potencies, and draw units required per 1.0 mg across standard research vials (2 mg, 5 mg, 10 mg) and diluent volumes (1 mL, 2 mL, 3 mL). All values follow the deterministic formula: Concentration (mg/mL) = Vial Mass (mg) ÷ Diluent Volume (mL).

Vial Mass (mg)	Diluent Added (mL)	Concentration (mg/mL)	Potency per Unit (mcg/U)	Units per 1.0 mg Draw
2 mg	1.0 mL	2.0 mg/mL	20.0 mcg/U	50.0 Units
2 mg	2.0 mL	1.0 mg/mL	10.0 mcg/U	100.0 Units
5 mg	1.0 mL	5.0 mg/mL	50.0 mcg/U	20.0 Units
5 mg	2.0 mL	2.5 mg/mL	25.0 mcg/U	40.0 Units
5 mg	3.0 mL	1.67 mg/mL	16.7 mcg/U	60.0 Units
10 mg	1.0 mL	10.0 mg/mL	100.0 mcg/U	10.0 Units
10 mg	2.0 mL	5.0 mg/mL	50.0 mcg/U	20.0 Units
10 mg	3.0 mL	3.33 mg/mL	33.3 mcg/U	30.0 Units

Worked Calculation Example: 5 mg Vial with 1.0 mL vs. 2.0 mL Diluent

Example Parameters:

Vial Mass: 5.0 mg solid lyophilized cake
Target Test Amount: 2.0 mg (2,000 mcg) illustrative calculation
Syringe Standard: U-100 insulin syringe (100 units = 1.0 mL, or 0.01 mL per unit)
Diluent Comparisons: 1.0 mL vs. 2.0 mL Bacteriostatic Water

Step-by-Step Calculation:

Option A (1.0 mL Diluent): Determine concentration = 5.0 mg ÷ 1.0 mL = 5.0 mg/mL (5,000 mcg/mL).
Option A Draw Volume: Volumetric draw = 2.0 mg ÷ 5.0 mg/mL = 0.40 mL.
Option A Syringe Units: 0.40 mL × 100 units/mL = 40.0 Units. This comfortably fits within a standard 0.5 mL (50-unit) syringe.
Option B (2.0 mL Diluent): Determine concentration = 5.0 mg ÷ 2.0 mL = 2.5 mg/mL (2,500 mcg/mL).
Option B Draw Volume: Volumetric draw = 2.0 mg ÷ 2.5 mg/mL = 0.80 mL.
Option B Syringe Units: 0.80 mL × 100 units/mL = 80.0 Units. This requires a 1.0 mL (100-unit) syringe and will overflow a 0.5 mL syringe.
Mathematical Back-Check (Option A): 40.0 units × 0.01 mL/unit = 0.40 mL. 0.40 mL × 5.0 mg/mL = 2.0 mg. Result confirms target mass.
Mathematical Back-Check (Option B): 80.0 units × 0.01 mL/unit = 0.80 mL. 0.80 mL × 2.5 mg/mL = 2.0 mg. Result confirms target mass.

Result:

Adding 1.0 mL yields a 40-unit draw for 2.0 mg; adding 2.0 mL yields an 80-unit draw for 2.0 mg.

Note: Notice that both options deliver the exact same 2.0 mg mass of active substance. Option A keeps the volumetric draw compact (0.40 mL), fitting smaller 0.5 mL syringes.

What Does 'TB-500' Mean? Chemical Ambiguity & Barrel Capacity Dynamics

Two unique considerations govern TB-500 reconstitution math:

1. Non-Standardized Nomenclature: In peer-reviewed biochemical literature, Thymosin Beta-4 is a defined 43-amino-acid polypeptide (molecular weight ~4,963 Da). In contrast, 'TB-500' is an unstandardized commercial trade term. Independent suppliers use this name interchangeably to sell either full-length synthetic Tβ4 or smaller synthetic fragments (such as Ac-LKKTET-OH, MW ~887 Da, representing the central actin-binding sequence). Reconstitution arithmetic determines the solution concentration based strictly on the gross milligrams entered; it cannot determine whether your vial contains the full 43-amino-acid protein or a fragment. Researchers must verify the molecular weight on their Certificate of Analysis (COA) to understand what compound they possess.

2. The Barrel-Capacity Threshold: Unlike BPC-157 where test amounts are small microgram quantities (requiring 5 to 20 units), TB-500 test amounts are measured in milligrams (1.0 mg to 5.0 mg). If a 5 mg vial is diluted in 2.0 mL of water, drawing 2.0 mg requires 80 units (0.80 mL). An investigator attempting to draw 80 units with a 0.5 mL (50-unit) syringe will run out of barrel space. When preparing TB-500, diluent volumes should be kept at 1.0 mL to 2.0 mL to ensure draw volumes remain manageable within standard 1.0 mL syringe barrels.

For a step-by-step primer on handling dilution calculations, consult our tutorial on how to calculate peptide dosage.

Syringe Barrel-Fit and Volume Compatibility (for 2.0 mg Target Draw)

Because TB-500 is measured in milligram quantities rather than microgram fractions, draw volumes can quickly exceed smaller syringe barrel capacities. Standard insulin syringes come in three barrel sizes: 0.3 mL (30 units), 0.5 mL (50 units), and 1.0 mL (100 units). This table identifies the smallest syringe barrel that safely holds an illustrative 2.0 mg test draw across various vial setups.

Vial Setup	Concentration	Draw Volume (mL)	U-100 Units	Smallest Fitting Syringe Barrel
10 mg in 1.0 mL	10.0 mg/mL	0.20 mL	20.0 Units	0.3 mL (30-unit) Barrel
5 mg in 1.0 mL	5.0 mg/mL	0.40 mL	40.0 Units	0.5 mL (50-unit) Barrel
10 mg in 3.0 mL	3.33 mg/mL	0.60 mL	60.0 Units	1.0 mL (100-unit) Barrel
5 mg in 2.0 mL	2.5 mg/mL	0.80 mL	80.0 Units	1.0 mL (100-unit) Barrel (Exceeds 50U Syringe)
5 mg in 3.0 mL	1.67 mg/mL	1.20 mL	120.0 Units	⚠️ Exceeds 1.0 mL Syringe (Requires Multiple Draws)

TB-500 Laboratory Handling & Storage Parameters

Synthetic Thymosin Beta-4 sequences are sensitive to high-shear fluid introduction and thermal denaturation. When adding bacteriostatic water, inject slowly against the interior glass wall so the diluent runs down the side, avoiding direct fluid jetting onto the lyophilized powder cake. Swirl gently in circular motions until the cake fully dissolves into a clear liquid. Do not shake vigorously.

Store reconstituted solutions upright in refrigeration between 2°C and 8°C (USP <659>). Under FDA multi-dose sterile vial guidance and USP <797> standards, multi-dose vials preserved with 0.9% benzyl alcohol should be discarded within 28 days of first puncture unless product labeling specifies a shorter limit. Never freeze liquid reconstituted peptide solutions. For complete standard operating procedures, review our step-by-step guide on how to reconstitute peptides safely.

Common Calculation & Measurement Mistakes

⚠️Assuming 'TB-500' Refers to a Single Standardized Molecule

Commercial vendors market both 43-amino-acid Thymosin Beta-4 and truncated synthetic fragments under the label 'TB-500'. Reconstitution math calculates concentration based on the stated milligram mass, but laboratory investigators must consult an analytical COA to verify molecular identity.

⚠️Ignoring Syringe Barrel Capacity

Because TB-500 involves milligram-scale test draws, volumetric draws frequently reach 60 to 80 units (0.6 to 0.8 mL). Attempting to draw 80 units using a 0.5 mL (50-unit) syringe will pull the plunger out of the barrel. Always confirm your syringe barrel capacity matches your calculated volume.

⚠️Applying BPC-157 Unit Numbers to TB-500

BPC-157 is calculated in micrograms (250 mcg = 0.25 mg), whereas TB-500 is calculated in milligrams (2.0 mg = 2,000 mcg). Reusing a 10-unit draw from a BPC-157 vial delivers only a fraction of intended TB-500 mass.

⚠️Using a U-40 Syringe for U-100 Calculations

U-100 syringes contain 100 units per mL (0.01 mL/unit). U-40 veterinary syringes contain 40 units per mL (0.025 mL/unit). Drawing 40 units on a U-40 syringe delivers 1.0 mL instead of 0.40 mL—causing an unintentional 2.5× volumetric error.

Comparing TB-500 Reconstitution Arithmetic with Related Peptides

Understanding how TB-500 arithmetic compares to neighboring research peptides prevents critical laboratory errors:

• Compared to BPC-157: BPC-157 is calculated in microgram increments (250 mcg to 500 mcg), resulting in small volumetric draws (typically 10 to 20 units). TB-500 protocols involve milligram-scale amounts (2.0 mg to 5.0 mg), requiring larger draw volumes (40 to 80 units) and careful attention to syringe barrel size.
• Compared to BPC-157 & TB-500 Blend: In pre-mixed co-lyophilized blend vials, both peptides are dissolved in the same diluent. Each peptide maintains its own independent concentration, and a single draw delivers both substances in proportion to their respective vial masses.
• Compared to KPV Peptide: KPV is an anti-inflammatory tripeptide whose arithmetic is heavily influenced by net peptide content factors. TB-500 calculations similarly depend on analytical COA verification.
• Compared to GHK-Cu: GHK-Cu vials contain vastly larger masses (50 mg to 100 mg), requiring larger reconstitution volumes (up to 5 mL).

Reconstitution Protocol Summary

Lyophilized TB-500 cake dissolves readily in bacteriostatic water when slow-injection techniques are observed.

Syringe Reading Diagram

U-100 Syringe Graduation & Measurement Line (TB-500)

Standard Reconstitution Protocol

Follow our standardized 5-step sterile reconstitution guide for full vial preparation, alcohol disinfection, and needle handling SOPs.

Universal Step-by-Step Reconstitution Guide→

❄️ Storage & Shelf-Life Notice (TB-500)

Reconstituted solutions containing 0.9% benzyl alcohol should be stored continuously refrigerated at 2°C–8°C (36°F–46°F). Never freeze reconstituted liquid solutions.

⚠️ Common Preparation Mistakes to Avoid

Common errors include assuming TB-500 has a standardized structure, ignoring syringe barrel capacity, and confusing U-40 with U-100 syringes.

TB-500 Dosing FAQ

Is TB-500 the same molecule as Thymosin Beta-4?↓

Not necessarily. In peer-reviewed literature, Thymosin Beta-4 is a specific 43-amino-acid protein. In the research chemical marketplace, 'TB-500' is an unstandardized label used for either full-length Tβ4 or synthetic fragments containing its active LKKTET actin-binding motif. Reviewing an analytical Certificate of Analysis with mass spectrometry is required to identify the specific molecule.

Why does my calculated draw not fit into a 0.5 mL (50-unit) syringe?↓

Because milligram-scale amounts of TB-500 frequently require 60 to 80 units (0.60 mL to 0.80 mL) of liquid. A 0.5 mL syringe only holds up to 50 units. For draws exceeding 50 units, you must use a standard 1.0 mL (100-unit) syringe barrel or reduce the volume of bacteriostatic water added to increase concentration.

What can a Certificate of Analysis (COA) confirm about TB-500?↓

An analytical COA provides high-performance liquid chromatography (HPLC) to verify purity percentage and mass spectrometry (MS) to verify molecular weight. This confirms whether the vial contains full-length Tβ4 (~4,963 Da) or a truncated fragment (~887 Da). It does not guarantee sterility or lack of endotoxins unless full microbiological testing was performed.

What happens if I use BPC-157 calculation numbers for TB-500?↓

BPC-157 is calculated in micrograms (such as 250 mcg), while TB-500 is calculated in milligrams (such as 2.0 mg). Applying BPC-157 draw units to a TB-500 vial will deliver an unintended fraction of active substance, as the two compounds operate on entirely different dosage scales.

Can TB-500 and BPC-157 be reconstituted in the same vial?↓

Only if acquired as a manufactured co-lyophilized blend vial. Adding liquid to two separate dry vials and combining them requires complex volume and concentration tracking. For pre-mixed vials, consult our dedicated BPC-157 and TB-500 blend calculator.

Related Peptide Calculators & Stacks

BPC-157

Calculate reconstitution volume, solution concentration, and U-100 syringe units for research BPC-157 vials.

Calculate BPC-157→

BPC-157 & TB-500 Blend

Calculate BPC-157 + TB-500 blend reconstitution, component ratio math, and U-100 syringe units.

Calculate BPC-157 & TB-500 Blend→

KPV

Calculate reconstitution volume, solution concentration, and U-100 syringe units for research KPV vials.

Calculate KPV→

Related Reconstitution & Dosing Guides

View All FAQs→

BPC-157 FAQ

How Much Bac Water for BPC-157?

→

General Peptide FAQ

How to Reconstitute Peptides?

→